The Immuno-oncology Therapy market report provides a detailed analysis of regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic.

And global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis,

COVID-19 Infact, Ukrainian-Russian War, China’s New COVID-19 Policy with Immuno-oncology Therapy Market

2023 will be a tough year for much of the global economy, as the ongoing war in Ukraine continues to strain trade, especially in Europe, and the global economy remains reeling from the fallout from the COVID-19 pandemic.

But as China moves ever closer to fully reemerging from three years of government-imposed Covid isolation and reintegrating with the world, economic expectations are high.

With the global economy now facing significant challenges, including energy shortages, slowing growth and high inflation, China’s reopening could provide a much-needed and timely boost.

The report researches and analyzes the influence of the Immuno-oncology Therapy industry in the new era of global post-COIVD-19 economy in 2023, and provides in-depth analysis and professional suggestions on the current development.

Immuno-oncology Therapy Market Competition list

    Amgen
    AstraZeneca
    Bristol-Myers Squibb
    Eli-Lilly
    Roche
    GlaxoSmithKline
    Janssen Biotech
    Merck
    Novartis
    Pfizer
    Sanofi

(Find more companies in our free sample!)

Market Segment by Product Type

Monoclonal Antibodies
Immune Checkpoint Inhibitors
Immune System Modulators
Cancer Vaccines
Others
......

Market Segment by Product Application

Hospitals
Ambulatory Surgical Center
Others
......

Market segment by Region, regional analysis covers

    North America (United States, Canada and Mexico)

    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

    South America (Brazil, Argentina, Colombia, and Rest of South America)

    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

Bottom-up and Top-down Approaches for This Report

Table of Contents

Global Immuno-oncology Therapy Market Report 2023, Forecast to 2028

1 Report Overview
1.1 Immuno-oncology Therapy Introduction
1.2 Report Structure Overview
1.3 Years Considered

2 Market Status
2.1 Global Immuno-oncology Therapy Market Outlook
2.2 Key Industry Perspective: What Industry Leaders are saying?
2.3 Global Demand Side Trends
2.4 Global Supply Side Trends
2.5 Value Chain Analysis
2.5.1 Raw Material Suppliers
2.5.2 Immuno-oncology Therapy Manufacturers
2.5.3 Distributors
2.6 Macro-Economic Factors
2.6.1 Global GDP Growth
2.6.2 Manufacturing Value Added
2.6.3 Industrial Production
2.7 Forecast Factors – Relevance & Impact
2.8 Market Dynamics
2.8.1 Market Opportunities
2.8.2 Market Risk
2.8.3 Market Driving Force
2.8.4 Product Innovation / Development Trends

3 Coronavirus Disease 2020 (COVID-19): Immuno-oncology Therapy Industry Impact
3.1 Current Statistics and Probable Future Impact
3.2 Comparison of SAARs and Market Recovery
3.3 Immuno-oncology Therapy Business Impact Assessment – Covid-19
3.4 Market Trends and Immuno-oncology Therapy Potential Opportunities in the COVID-19 Landscape

4 Production by Region
4.1 Global Immuno-oncology Therapy Production (History Data) by Region (2018-2023)
4.2 Global Immuno-oncology Therapy Production Value (History Data) by Region
4.3 North America
4.3.1 North America Immuno-oncology Therapy Production Growth Rate 2018-2023
4.3.2 North America Immuno-oncology Therapy Production Value Growth Rate 2018-2023
4.3.3 Key Players in North America
4.3.4 North America Immuno-oncology Therapy Import & Export
4.4 Europe
4.4.1 Europe Immuno-oncology Therapy Production Growth Rate 2018-2023
4.4.2 Europe Immuno-oncology Therapy Production Value Growth Rate 2018-2023
4.4.3 Key Players in Europe
4.4.4 Europe Immuno-oncology Therapy Import & Export
4.5 Japan
4.5.1 Japan Immuno-oncology Therapy Production Growth Rate 2018-2023
4.5.2 Japan Immuno-oncology Therapy Production Value Growth Rate 2018-2023
4.5.3 Key Players in Japan
4.5.4 Japan Immuno-oncology Therapy Import & Export
4.6 China
4.6.1 China Immuno-oncology Therapy Production Growth Rate 2018-2023
4.6.2 China Immuno-oncology Therapy Production Value Growth Rate 2018-2023
4.6.3 Key Players in China
4.6.4 China Immuno-oncology Therapy Import & Export
4.7 Southeast Asia
4.7.1 Southeast Asia Immuno-oncology Therapy Production Growth Rate 2018-2023
4.7.2 Southeast Asia Immuno-oncology Therapy Production Value Growth Rate 2018-2023
4.7.3 Key Players in Southeast Asia
4.7.4 Southeast Asia Immuno-oncology Therapy Import & Export
4.8 India
4.8.1 India Immuno-oncology Therapy Production Growth Rate 2018-2023
4.8.2 India Immuno-oncology Therapy Production Value Growth Rate 2018-2023
4.8.3 Key Players in India
4.8.4 India Immuno-oncology Therapy Import & Export

5 Immuno-oncology Therapy Consumption by Region
5.1 Global Immuno-oncology Therapy Consumption (History Data) by Region
5.2 North America
5.2.1 North America Immuno-oncology Therapy Consumption by Type
5.2.2 North America Immuno-oncology Therapy Consumption by Application
5.2.3 North America Immuno-oncology Therapy Consumption by Countries
5.2.4 United States
5.2.5 Canada
5.2.6 Mexico
5.3 Europe
5.3.1 Europe Immuno-oncology Therapy Consumption by Type
5.3.2 Europe Immuno-oncology Therapy Consumption by Application
5.3.3 Europe Immuno-oncology Therapy Consumption by Countries
5.3.4 Germany
5.3.5 France
5.3.6 UK
5.3.7 Italy
5.3.8 Russia
5.3.9 Spain
5.4 Asia Pacific
5.4.1 Asia Pacific Immuno-oncology Therapy Consumption by Type
5.4.2 Asia Pacific Immuno-oncology Therapy Consumption by Application
5.4.3 Asia Pacific Immuno-oncology Therapy Consumption by Region
5.4.4 China
5.4.5 Japan
5.4.6 South Korea
5.4.7 India
5.4.8 Australia
5.4.9 Spain
5.4.10 Thailand
5.4.11 Malaysia
5.4.12 Philippines
5.4.13 Vietnam
5.5 Central & South America
5.5.1 Central & South America Immuno-oncology Therapy Consumption by Type
5.5.2 Central & South America Immuno-oncology Therapy Consumption by Application
5.5.3 Central & South America Immuno-oncology Therapy Consumption by Countries
5.5.4 Brazil
5.6 Middle East and Africa
5.6.1 Middle East and Africa Immuno-oncology Therapy Consumption by Type
5.6.2 Middle East and Africa Immuno-oncology Therapy Consumption by Application
5.6.3 Middle East and Africa Immuno-oncology Therapy Consumption by Countries
5.6.4 GCC Countries
5.6.5 Turkey
5.6.6 Egypt
5.6.7 South Africa
5.6.8 Israel

6 Global Immuno-oncology Therapy Market Segment by Type
6.1 Introduction / Key Findings
6.2 Global Immuno-oncology Therapy Revenue, Sales and Market Share by Type (2018-2023)
6.2.1 Global Immuno-oncology Therapy Sales and Market Share by Type (2018-2023)
6.2.2 Global Immuno-oncology Therapy Revenue and Market Share by Type (2018-2023)
6.3 Monoclonal Antibodies Sales Growth Rate and Price
6.3.1 Global Monoclonal Antibodies Sales Growth Rate (2018-2023)
6.3.2 Global Monoclonal Antibodies Price (2018-2023)
6.4 Immune Checkpoint Inhibitors Sales Growth Rate and Price
6.4.1 Global Immune Checkpoint Inhibitors Sales Growth Rate (2018-2023)
6.4.2 Global Immune Checkpoint Inhibitors Price (2018-2023)
6.5 Immune System Modulators Sales Growth Rate and Price
6.5.1 Global Immune System Modulators Sales Growth Rate (2018-2023)
6.5.2 Global Immune System Modulators Price (2018-2023)
6.6 Cancer Vaccines Sales Growth Rate and Price
6.6.1 Global Cancer Vaccines Sales Growth Rate (2018-2023)
6.6.2 Global Cancer Vaccines Price (2018-2023)
6.7 Others Sales Growth Rate and Price
6.7.1 Global Others Sales Growth Rate (2018-2023)
6.7.2 Global Others Price (2018-2023)

7 Global Immuno-oncology Therapy Market Segment by Application
7.1 Introduction / Key Findings
7.2 Global Immuno-oncology Therapy Sales Market Share by Application (2018-2023)
7.3 Hospitals Sales Growth Rate (2018-2023)
7.4 Ambulatory Surgical Center Sales Growth Rate (2018-2023)
7.5 Others Sales Growth Rate (2018-2023)

8 Analysis of Key Players
8.1 Amgen
8.1.1 Company Details
8.1.2 Description and Business Overview
8.1.3 Product Introduction
8.1.4 Amgen Immuno-oncology Therapy Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
8.1.5 Recent News
8.2 AstraZeneca
8.2.1 Company Details
8.2.2 Description and Business Overview
8.2.3 Product Introduction
8.2.4 AstraZeneca Immuno-oncology Therapy Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
8.2.5 Recent News
8.3 Bristol-Myers Squibb
8.3.1 Company Details
8.3.2 Description and Business Overview
8.3.3 Product Introduction
8.3.4 Bristol-Myers Squibb Immuno-oncology Therapy Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
8.3.5 Recent News
8.4 Eli-Lilly
8.4.1 Company Details
8.4.2 Description and Business Overview
8.4.3 Product Introduction
8.4.4 Eli-Lilly Immuno-oncology Therapy Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
8.4.5 Recent News
8.5 Roche
8.5.1 Company Details
8.5.2 Description and Business Overview
8.5.3 Product Introduction
8.5.4 Roche Immuno-oncology Therapy Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
8.5.5 Recent News
8.6 GlaxoSmithKline
8.6.1 Company Details
8.6.2 Description and Business Overview
8.6.3 Product Introduction
8.6.4 GlaxoSmithKline Immuno-oncology Therapy Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
8.6.5 Recent News
8.7 Janssen Biotech
8.7.1 Company Details
8.7.2 Description and Business Overview
8.7.3 Product Introduction
8.7.4 Janssen Biotech Immuno-oncology Therapy Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
8.7.5 Recent News
8.8 Merck
8.8.1 Company Details
8.8.2 Description and Business Overview
8.8.3 Product Introduction
8.8.4 Merck Immuno-oncology Therapy Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
8.8.5 Recent News
8.9 Novartis
8.9.1 Company Details
8.9.2 Description and Business Overview
8.9.3 Product Introduction
8.9.4 Novartis Immuno-oncology Therapy Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
8.9.5 Recent News
8.10 Pfizer
8.10.1 Company Details
8.10.2 Description and Business Overview
8.10.3 Product Introduction
8.10.4 Pfizer Immuno-oncology Therapy Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
8.10.5 Recent News
8.11 Sanofi
8.11.1 Company Details
8.11.2 Description and Business Overview
8.11.3 Product Introduction
8.11.4 Sanofi Immuno-oncology Therapy Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
8.11.5 Recent News
8.12 Spectrum Pharmaceuticals
8.12.1 Company Details
8.12.2 Description and Business Overview
8.12.3 Product Introduction
8.12.4 Spectrum Pharmaceuticals Immuno-oncology Therapy Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
8.12.5 Recent News
8.13 Takeda
8.13.1 Company Details
8.13.2 Description and Business Overview
8.13.3 Product Introduction
8.13.4 Takeda Immuno-oncology Therapy Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
8.13.5 Recent News

9 Immuno-oncology Therapy Market Forecast
9.1 Forecast Factors – Relevance & Impact
9.1.1 Factor 1
9.1.2 Factor 2
9.1.3 Factor 3
9.2 Global Immuno-oncology Therapy Revenue, Sales and Growth Rate (2023-2028)
9.3 Immuno-oncology Therapy Market Forecast by Regions (2023-2028)
9.3.1 North America Immuno-oncology Therapy Market Forecast (2023-2028)
9.3.2 Europe Immuno-oncology Therapy Market Forecast (2023-2028)
9.3.3 Asia-Pacific Immuno-oncology Therapy Market Forecast (2023-2028)
9.3.4 South America Immuno-oncology Therapy Market Forecast (2023-2028)
9.3.5 Middle East & Africa Immuno-oncology Therapy Market Forecast (2023-2028)
9.4 Immuno-oncology Therapy Market Forecast by Type (2023-2028)
9.4.1 Global Immuno-oncology Therapy Consumption Forecast by Type (2023-2028)
9.4.2 Global Immuno-oncology Therapy Consumption Market Share Forecast by Type (2023-2028)
9.5 Immuno-oncology Therapy Market Forecast by Application (2023-2028)
9.5.1 Global Immuno-oncology Therapy Consumption Forecast by Application (2023-2028)
9.5.2 Global Immuno-oncology Therapy Market Share Forecast by Application (2023-2028)

10 Conclusion

The process of data collection, processing and analysis relies on internal database call, computer simulation processing and manual evaluation. The process is more complicated, and the detailed data model involved is confidential and should not be disclosed. Here I can give you a brief description of the principle of data calculation.

Data collection: The data collection process comes from our database. Our global clerks will keep track of the companies that have been entered in the database and update them from time to time. The data we pay attention to include the company’s revenue, product type, output, price, sales area, import and export capabilities, and the company’s large-scale capital flow in recent years.

Data processing: In this process, basic data is applied through mathematical models to form processed data that can represent the development status of the industry over a period of time. The establishment and selection of mathematical models fit the product category and market environment.

Data analysis: In this process, professional analysts will combine the data obtained above with human factors such as regional economic development, product updates, and the issuance of special laws. Get the forecast of the mainstream market in the future.